Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax® compared with Turbuhaler® in patients with moderate-to-severe chronic obstructive pulmonary disease in S
about
Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax® compared with Turbuhaler® in patients with moderate-to-severe chronic obstructive pulmonary disease in S
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Estimating the economic conseq ...... ructive pulmonary disease in S
@en
Estimating the economic conseq ...... ructive pulmonary disease in S
@nl
type
label
Estimating the economic conseq ...... ructive pulmonary disease in S
@en
Estimating the economic conseq ...... ructive pulmonary disease in S
@nl
prefLabel
Estimating the economic conseq ...... ructive pulmonary disease in S
@en
Estimating the economic conseq ...... ructive pulmonary disease in S
@nl
P2093
P2860
P356
P1476
Estimating the economic conseq ...... ructive pulmonary disease in S
@en
P2093
Adi Bijedic
Diego Vargas
Gabriela Ramírez
Josep Darbà
José Francisco Pascual
Juan L García-Rivero
Sagrario Mayoralas
P2860
P304
P356
10.2147/CEOR.S125301
P407
P577
2017-02-10T00:00:00Z